Triggering receptor expressed on myeloid cells 2 (TREM2) has been shown with a neuroprotective function against inflammation and neuronal injury in Alzheimer’s disease (AD). This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.